CHI3L1 and Parkinson disease: As melatonin suppresses LPS-induced YKL-40 [182] and acts in an autocrine manner to suppress glia activation, alterations in the availability of local melatonin and its capacity to be regulated by butyrate will be important to determine across cell types in PD patients and preclinical models.